This activity will bring a leading clinical investigator to your cancer center to discuss emerging data on PARP inhibitors that can rationally inform the management of ovarian cancer. Enroll your institution today!
Format: CME-certified visiting faculty lecture series
In this case-based activity, Pamela Ryan, RN, BSN from Ochsner Medical Center and Donna Williams, RN from Stanford Medicine discuss signs and symptoms of carcinoid syndrome in patients with neuroendocrine tumors and the application of supportive care strategies to provide symptom relief. Participate from the comfort of your home or office!
Format: CE-certified online activity
This activity will bring a leading clinical investigator to your cancer center to discuss emerging data on targeted therapies in the treatment of patients with advanced renal cell carcinoma. Enroll your institution today.
Format: CME-certified visiting faculty meeting series
In this case-based activity, Rebecca Clark-Snow, RN, BSN, OCN® and Una T. Hopkins, DNP discuss CINV risk assessment, emetic risk, antiemetic regimens, and self report in high-risk patients. Participate from the comfort of your home or office.
Format: CE-certified online activity
Watch this CME/CE-certified discussion with Tanya Dorff, MD from the Keck School of Medicine as she discusses progress in our understanding of predictive/prognostic markers in advanced prostate cancer as well as optimizing treatment sequencing and response assessment. Participate from the comfort of your home or office.
Format: CME/CE-certified online activity
This expert-led live meeting will discuss individualized treatment planning for patients with MBC. Participants will learn about CDK4/6 inhibitor safety profiles and the use of supportive care planning to mitigate AEs. Book this meeting at your institution now!
Format: CE-certified visiting faculty meeting series
Immunotherapy is disrupting cancer care! This activity will bring a clinical expert to your cancer center to share insights into how immune checkpoint inhibitors can enhance the survival outcomes of patients with metastatic MCC. Enroll your institution now.
Format: CME/CE-certified visiting faculty meeting series
This activity features an expert-led, case-based discussion with Thomas A. Abrams, MD from Dana-Farber Cancer Institute and Harvard Medical School on evolving antiangiogenic strategies with multikinase inhibitors in first- and second-line treatment of advanced HCC. Participate from the comfort of your home or office.
Format: CME/CE-certified online activity
Veno-occlusive disease, also known as sinusoidal obstruction syndrome, is a potentially life-threatening complication of hematopoietic stem cell transplant. Watch this expert-led discussion on nursing management best practices.
Format: CE-certified online activity
This activity will bring a leading clinical investigator to your cancer center to discuss and debate evidence-based best practices in the management of relapsed/refractory diffuse large B-cell lymphoma. Request a meeting for your institution today!
Format: CME-certified visiting faculty meeting series
This activity will bring a leading clinical investigator to your hematology/oncology fellowship program to discuss emerging data that can rationally inform the management of hematologic malignancies with stem cell transplant. Enroll your institution today!
Format: CME-certified visiting professor lecture series
In this case-based activity, leading clinical investigator Jochen Lorch, MD, MS from Dana-Farber Cancer Institute will share insights into evidence-based personalized care planning for patients with differentiated and medullary thyroid cancer. Participate from the comfort of your home or office.
Format: CME-certified online activity
This activity will bring a leading clinical investigator to your hematology/oncology fellowship program to examine current challenges, new opportunities, and future directions in the management of CLL. Enroll your institution today!
Format: CME-certified visiting professor lecture series
In this case-based activity, leading clinical investigator Oliver Sartor, MD examines recent developments and best practices in treatment selection and supportive care planning for patients with metastatic castration-resistent prostate cancer.
Format: CME-certified online activity
This activity will bring a leading clinical investigator to your hematology/oncology fellowship program to discuss the latest advances in antiemetic strategies for high-risk patients receiving cytotoxic chemotherapy. Enroll your institution today.
Format: CME-certified visiting professor lecture series
